These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 35055387)

  • 1. Identifying the Steps Required to Effectively Implement Next-Generation Sequencing in Oncology at a National Level in Europe.
    Horgan D; Curigliano G; Rieß O; Hofman P; Büttner R; Conte P; Cufer T; Gallagher WM; Georges N; Kerr K; Penault-Llorca F; Mastris K; Pinto C; Van Meerbeeck J; Munzone E; Thomas M; Ujupan S; Vainer GW; Velthaus JL; André F
    J Pers Med; 2022 Jan; 12(1):. PubMed ID: 35055387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Framework for Adoption of Next-Generation Sequencing (NGS) Globally in the Oncology Area.
    Horgan D; Hamdi Y; Lal JA; Nyawira T; Meyer S; Kondji D; Francisco NM; De Guzman R; Paul A; Bernard B; Reddy Nallamalla K; Park WY; Triapthi V; Tripathi R; Johns A; Singh MP; Phipps ME; Dube F; Rasheed HMA; Kozaric M; Pinto JA; Doral Stefani S; Aponte Rueda ME; Fujita Alarcon R; Barrera-Saldana HA
    Healthcare (Basel); 2023 Feb; 11(3):. PubMed ID: 36767006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tackling Thyroid Cancer in Europe-The Challenges and Opportunities.
    Horgan D; Führer-Sakel D; Soares P; Alvarez CV; Fugazzola L; Netea-Maier RT; Jarzab B; Kozaric M; Bartes B; Schuster-Bruce J; Dal Maso L; Schlumberger M; Pacini F
    Healthcare (Basel); 2022 Aug; 10(9):. PubMed ID: 36141235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular tests and target therapies in oncology: recommendations from the Italian workshop.
    Pinto C; Biffoni M; Popoli P; Marchetti A; Marchetti P; Martini N; Normanno N
    Future Oncol; 2021 Sep; 17(26):3529-3539. PubMed ID: 34254524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Access and quality of biomarker testing for precision oncology in Europe.
    Normanno N; Apostolidis K; Wolf A; Al Dieri R; Deans Z; Fairley J; Maas J; Martinez A; Moch H; Nielsen S; Pilz T; Rouleau E; Patton S; Williams V
    Eur J Cancer; 2022 Nov; 176():70-77. PubMed ID: 36194905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerating the Development and Validation of Liquid Biopsy for Early Cancer Screening and Treatment Tailoring.
    Horgan D; Čufer T; Gatto F; Lugowska I; Verbanac D; Carvalho Â; Lal JA; Kozaric M; Toomey S; Ivanov HY; Longshore J; Malapelle U; Hasenleithner S; Hofman P; Alix-Panabières C
    Healthcare (Basel); 2022 Sep; 10(9):. PubMed ID: 36141326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precision cancer medicine: What has translated into clinical use in Belgium?
    Delnord M; Van Valckenborgh E; Hebrant A; Antoniou A; Van Hoof W; Waeytens A; Van den Bulcke M
    Semin Cancer Biol; 2022 Sep; 84():255-262. PubMed ID: 34129914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validating Comprehensive Next-Generation Sequencing Results for Precision Oncology: The NCT/DKTK Molecularly Aided Stratification for Tumor Eradication Research Experience.
    Lier A; Penzel R; Heining C; Horak P; Fröhlich M; Uhrig S; Budczies J; Kirchner M; Volckmar AL; Hutter B; Kreutzfeldt S; Endris V; Richter D; Wolf S; Pfütze K; Neumann O; Buchhalter I; Morais de Oliveira CM; Singer S; Leichsenring J; Herpel E; Klauschen F; Jost PJ; Metzeler KH; Schulze-Osthoff K; Kopp HG; Kindler T; Rieke DT; Lamping M; Brandts C; Falkenhorst J; Bauer S; Schröck E; Folprecht G; Boerries M; von Bubnoff N; Weichert W; Brors B; Lichter P; von Kalle C; Schirmacher P; Glimm H; Fröhling S; Stenzinger A
    JCO Precis Oncol; 2018 Nov; 2():1-13. PubMed ID: 35135162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tackling the implementation gap for the uptake of NGS and advanced molecular diagnostics into healthcare systems.
    Horgan D; Van den Bulcke M; Malapelle U; Troncone G; Normanno N; Capoluongo ED; Prelaj A; Rizzari C; Trapani D; Singh J; Kozaric M; Longshore J; Ottaviano M; Boccia S; Pravettoni G; Cattaneo I; Malats N; Buettner R; Lekadir K; de Lorenzo F; Hofman P; De Maria R
    Heliyon; 2024 Jan; 10(1):e23914. PubMed ID: 38234913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fighting Cancer around the World: A Framework for Action.
    Horgan D; Mia R; Erhabor T; Hamdi Y; Dandara C; Lal JA; Domgue JF; Ewumi O; Nyawira T; Meyer S; Kondji D; Francisco NM; Ikeda S; Chuah C; De Guzman R; Paul A; Reddy Nallamalla K; Park WY; Tripathi V; Tripathi R; Johns A; Singh MP; Phipps ME; Dube F; Whittaker K; Mukherji D; Rasheed HMA; Kozaric M; Pinto JA; Doral Stefani S; Augustovski F; Aponte Rueda ME; Fujita Alarcon R; Barrera-Saldana HA
    Healthcare (Basel); 2022 Oct; 10(11):. PubMed ID: 36360466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How can a joint European health technology assessment provide an 'additional benefit' over the current standard of national assessments? : Insights generated from a multi-stakeholder survey in hematology/oncology.
    Julian E; Gianfrate F; Sola-Morales O; Mol P; Bergmann JF; Salmonson T; Hebborn A; Grande M; Ruof J
    Health Econ Rev; 2022 Jun; 12(1):30. PubMed ID: 35652987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommendations for the use of next-generation sequencing in patients with metastatic cancer in the Asia-Pacific region: a report from the APODDC working group.
    Loong HH; Shimizu T; Prawira A; Tan AC; Tran B; Day D; Tan DSP; Ting FIL; Chiu JW; Hui M; Wilson MK; Prasongsook N; Koyama T; Reungwetwattana T; Tan TJ; Heong V; Voon PJ; Park S; Tan IB; Chan SL; Tan DSW
    ESMO Open; 2023 Aug; 8(4):101586. PubMed ID: 37356359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical Care Network in the State of Qatar.
    Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF
    Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anniversary Oncology Days in Paris.
    Baltaga R
    Exp Oncol; 2023 Dec; 45(3):273-274. PubMed ID: 38186028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roadbook for the implementation of next-generation sequencing in clinical practice in oncology and hemato-oncology in Belgium.
    Van Valckenborgh E; Hébrant A; Antoniou A; Van Hoof W; Van Bussel J; Pauwels P; Salgado R; Van Doren W; Waeytens A; Van den Bulcke M
    Arch Public Health; 2018; 76():49. PubMed ID: 30202522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A scoping study to explore the cost-effectiveness of next-generation sequencing compared with traditional genetic testing for the diagnosis of learning disabilities in children.
    Beale S; Sanderson D; Sanniti A; Dundar Y; Boland A
    Health Technol Assess; 2015 Jun; 19(46):1-90. PubMed ID: 26132578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group.
    Mosele F; Remon J; Mateo J; Westphalen CB; Barlesi F; Lolkema MP; Normanno N; Scarpa A; Robson M; Meric-Bernstam F; Wagle N; Stenzinger A; Bonastre J; Bayle A; Michiels S; Bièche I; Rouleau E; Jezdic S; Douillard JY; Reis-Filho JS; Dienstmann R; André F
    Ann Oncol; 2020 Nov; 31(11):1491-1505. PubMed ID: 32853681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Real-World Evidence in US Payer Coverage Decision-Making for Next-Generation Sequencing-Based Tests: Challenges, Opportunities, and Potential Solutions.
    Deverka PA; Douglas MP; Phillips KA
    Value Health; 2020 May; 23(5):540-550. PubMed ID: 32389218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.